1,3-Thiazol-5-ylmethyl [(2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenyl-2-hexanyl]carbamate(CAS: 144164-11-4)

This compound is subject to various regulatory guidelines including REACH in the EU for registration, evaluation, authorization, and restriction of chemical substances. It should comply with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labeling. FDA may regulate it as a pharmaceutical ingredient, and EPA may oversee its environmental impact and disposal under the Toxic Substances Control Act (TSCA).

Synthetic alternatives include using isomers or analogs such as 1,3-thiazol-5-ylmethyl [(2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenyl-2-hexan-1-yl]carbamate. Common alternative reagents might include other amino acids or thiazole derivatives depending on the specific synthesis process requirements.

Recent market trends indicate increasing research and development interest in this compound, particularly in pharmaceutical applications due to its potential as a drug candidate. Price trends reflect growing demand, but research efforts focus on optimizing synthesis and exploring new therapeutic potentials.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Environmental protection precautions include neutralizing the waste to minimize environmental impact before disposal. Incineration or chemical destruction methods may also be considered, ensuring compliance with local regulations and safety standards.